(Q46757287)

24 December 2017

title

Is combined androgen blockade with bicalutamide cost-effective compared with combined androgen blockade with flutamide? (English)

1 reference

24 December 2017

1 reference

David Penson

6

0 references

author name string

Scott Ramsey

1

1 reference

24 December 2017

David Veenstra

2

1 reference

24 December 2017

Lauren Clarke

3

1 reference

24 December 2017

Sanjay Gandhi

4

1 reference

24 December 2017

Mark Hirsch

5

1 reference

24 December 2017

language of work or name

English

0 references

publication date

1 October 2005

1 reference

24 December 2017

published in

Urology

1 reference

24 December 2017

volume

66

1 reference

24 December 2017

issue

4

1 reference

24 December 2017

page(s)

835-839

1 reference

24 December 2017

Clinical benefits of bicalutamide compared with flutamide in combined androgen blockade for patients with advanced prostatic carcinoma: final report of a double-blind, randomized, multicenter trial. Casodex Combination Study Group

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.04.028

Cost-effectiveness of androgen suppression therapies in advanced prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.04.028

Stage, age, comorbidity, and direct costs of colon, prostate, and breast cancer care

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.04.028

What is the price of life and why doesn't it increase at the rate of inflation?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.04.028

Role of perspective and other uncertainties in cost-effectiveness assessments in advanced prostate cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.04.028

A re-assessment of the role of combined androgen blockade for advanced prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.04.028

Systematic review and meta-analysis of monotherapy compared with combined androgen blockade for patients with advanced prostate carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.04.028

The cost-effectiveness of combined androgen blockade with bicalutamide and luteinizing hormone releasing hormone agonist in men with metastatic prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.04.028

10.1016/J.UROLOGY.2005.04.028

7 January 2021

Identifiers

DOI

1 reference

24 December 2017

release_cpzz2zasozabbegnrmum4y46si

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/cpzz2zasozabbegnrmum4y46si

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

24 December 2017